Table 3.
NET | VMAT 1 | VMAT 2 | |
---|---|---|---|
Total protein | 10 μg | 40 μg | 40 μg |
Type of gel | 8% Tris-Glycine gel | 4-12% NuPAGE Bis-Tris gel | 4-12% NuPAGE Bis-Tris gel |
Blocking buffer | I-block buffer (1X PBS, 0.1%tween-20, 0.02% sodium azide, 0.2% I-block dry powder (Applied Biosystems, Foster City, CA, USA) | TBS-T and 5% normal donkey serum (Jackson Immuno, Westgrove, PA, USA) | TBS-T and 5% dry milk |
Primary antibody | Rabbit anti-human NET polyclonal antibody (kind gift from Dr David Christie, University of Auckland, refs 13, 14), 1:250, 72 h at 4 °C | Goat anti-human VMAT 1 polyclonal antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA), 1:2000, 1 h at RT | Rabbit anti-human VMAT 2 polyclonal antibody (Chemicon, Temecula, CA, USA) |
Secondary antibody | Alkaline phosphatase conjugated anti-rabbit IgG, 1:5000, 45 min at RT | Horseradish peroxidase conjugated anti-goat IgG, 1:2000, 1 h at RT | Horseradish peroxidase conjugated anti-goat IgG, 1:20 000, 1 h at RT |
Immunodetection system | CDP-Star chemiluminescent method (Applied Biosystems) | Chemiluminescent method and using NIH image 1.62 software to perform densitometry analyses | Chemiluminescent method and using NIH image 1.62 software to perform densitometry analyses |
NET, noradrenaline transporter; RT, room temperature.